Sciwind Biosciences
Hangzhou
About Sciwind Biosciences
Sciwind Biosciences is a developers of drugs intended to treat metabolic disorders. The company's drugs contain protein and peptide candidates for non-alcoholic steatohepatitis, enabling physicians to treat their patients in an enhanced way.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Total funding: $136.3M
- Funding stage: Late Stage Venture
- Last round: Series C (Oct 2021)
- Website: sciwind.com.cn
Industries & Categories
Biotechnology, Health Care, Pharmaceutical
Canonical: https://fsome.com/organization/sciwind-biosciences-45189 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.